Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.
Ostrin, Edwin Justin	University Of Tx Md Anderson Can Ctr United States	Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort	1U01CA295902-01A1	Claire Zhu, Ph.D.
Palefsky, Joel Michael	University Of California, San Francisco United States	California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations	3U54CA242646-06S3	Maria Silvina Frech, Ph.D., M.S.
Palesh, Oxana G	Virginia Commonwealth University United States	Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia	5R01CA239714-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	5R01CA258221-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	5R01CA258221-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06	Matthew Young, Ph.D.
Panigrahy, Dipak	Beth Israel Deaconess Medical Center United States	Control of cancer cachexia via stimulation of resolution of inflammation	5R01CA276107-02	Marjorie Perloff, M.D.
Panikkar, Rajiv	Geisinger Clinic United States	Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)	3UG1CA189847-11S1	Vanessa A. White, M.P.H.
Papachristodoulou, Alexandros	Rutgers Biomedical And Health Sciences United States	Investigating mitochondrial dysfunction in high-risk prostate cancer	4R00CA276713-03	Vignesh Gunasekharan, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-08	Nicholas Hodges, Ph.D.
Park, Youngkyu	Cold Spring Harbor Laboratory United States	Preclinical Models for Cancer Therapeutic Development	5R50CA211506-10	Marjorie Perloff, M.D.
Paskett, Electra D.	Alliance Nctn Foundation United States	Alliance NCORP Research Base	3UG1CA189823-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Paulovich, Amanda G	Fred Hutchinson Cancer Center United States	Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment	5U2CCA271873-03	Sidney Fu, M.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	Matthew Young, Ph.D.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants